Skip to main content

College of
Health Sciences

Stephen J. Voyce, MD, FACC, FACP, FSCAI

Stephen J. Voyce, MD, FACC, FACP, FSCAI
Professor of Cardiology
Department of Medical Education 
Geisinger Commonwealth School of Medicine
Geisinger Heart & Vascular Institute
570-703-4830
svoyce@geisinger.edu

Stephen J. Voyce, MD, FACC, FACP, FSCAI

Research interests

Anticoagulation in cardiovascular disease, acute coronary syndromes, congestive heart failure, atrial fibrillation, Implementation science

Education

  • Wilkes College, Hahnemann/Drexel University School of Medicine
  • Internal Medicine Residency, Cardiology Fellowship and Interventional Cardiology Fellowship at University of Massachusetts Medical Center

Recent Publications

  • Williams BA; Blankenship JC; Voyce SJ; Jameson BC; Geba, D; Cordova JM; Gandhi, P. Shetty SS. A Cardiovascular Death Risk Prediction Model for Patients with Type 2 Diabetes Developed from Electronic Medical Record Data. Under review Cardiovascular Diabetology 2020
  • Williams BA, Chamberlain AM, Blankenship JC, Hylek EM, Voyce S. Trends in Atrial Fibrillation Incidence Rates Within an Integrated Health Care Delivery System, 2006-2018. JAMA Netw Open 2020; 3(8): e2014874.
  • Williams BA, Blankenship JC, Voyce S, Cordova JM, Gandhi P, Shetty SS. Quantifying the Risk Continuum for Cardiovascular Death in Adults with Type 2 Diabetes. Can J Diabetes. 2021 Oct;45(7):650-658.e2. doi: 10.1016/j.jcjd.2021.01.009. Epub 2021 Jan 23. PMID: 33773935.
  • Williams BA, Riangwiwat T, Voyce SJ, Blankenship JC. Burden and Predictors of Chest Pain-Related Health-Care Utilization Following Percutaneous Coronary Intervention. Am J Cardiology. 160.2021 p31-39. https://doi.org/10.1016/j.amjcard.2021.07.051.
  • Williams BA, Voyce S, Sidney S, Roger VL, Plante TB, Larson S, LaMonte MJ, Labarth DR, DeBarmore BM, Change AR, Chamberlain AM, Benziger CP. Establishing a National Cardiovascular Disease Surveillance System in the United States Using Electronic Health Record Data: Key Strengths and Limitations. 12 Apr 2022 https://doi.org/10.1161/JAHA.121.024409 Journal of the American Heart Association. 2022;11: e024409
  • Williams BA, Brady JP, Voyce S, Kumar N, Paprocki Y. Changes Over Time in the Cardiovascular Risk Profile of Type 2 Diabetes from 2007-2020: A Community Based Study. Diabetes. Obesity and Metabolism. 07 March 2022 https://doi.org/10.1111/dom.14686
  • Grampp SJ, Manko CD, Boruah P, Voyce S (2022) Unusual Cause of a Left Ventricular Mass in an Octogenarian with Metastatic Squamous Cell Lung Cancer. Int J Clin Cardiol 9:270. doi.org/10.23937/2378-2951/1410270P
  • Williams BA, Voyce S, Blankenship JC, Chang AR. Association between the diagnostic classification of newly diagnosed coronary artery disease and future heart failure development. Coron Artery Dis. 2023 Aug 1;34(5):341-350. doi: 10.1097/MCA.0000000000001243. Epub 2023 May 1. PMID: 37139564.
  • Vijayaraghavan K, Baum S, Desai NR, Voyce S.. Intermediate and Long-term Residual Cardiovascular Risk in Patients with Established Cardiovascular Disease Treated with Statins. Front Cardiovasc Med. 2024 Jan 15;10:1308173. doi: 10.3389/fcvm.2023.1308173. PMID: 38288054; PMCID: PMC10822878.
  • Graham J, Voyce SJ, Hayden JR, Chopra A, Tinsley J, Singh N, Eslami A, Grassi S, Zook A, Lauver B, Eckel S, Hayduk VA, Kern MS, Agarwal S, Wright E, Evaluation of pharmacist-led transition of care program in patients with acute coronary syndrome, Journal of the American Pharmacists Association (2024), doi: https://doi.org/10.1016/j.japh.2024.01.019.
  • Pradhan AM, Lussier M, Nguyen M, Voyce S, Wright E. Qualitative Evaluation to Understand Barriers and Facilitators to Prescribing Angiotensin Receptor-Neprilysin Inhibitors (ARNi) and Sodium-Glucose Cotransporter Inhibitors (SGLT2i) in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF). Journal of the American Pharmacists Association 2024 Vol 64, 6, 10224. https://doi.org/10.1016/j.japh.2024.102224
  • Williams BA, Blankenship J, Voyce S, Chang A. Trends Over Time in Oral Anticoagulation and Stroke Rates in Atrial Fibrillation: A Community-Based Study. Accepted for publication. Journal of Stroke and Cerebrovascular Disease. 2024

Current Research Projects

  • GREAT-HF Care (Eric Wright, PharmD, MPH, Amir Goren, PhD, Apoorva Pradhan, MPH, Vanessa Hayduk, MS)
  • DAPA-AHF (Rebecca Mack, RN, Pranjal Boruah, MD)
  • Incidental Coronary Calcium Discovered on CT Scan (Matthew Facktor, MD, John Debardeleben, MD, Jiatian Qu, MS4, Dylan Quinn, MS4)
  • Anticoagulation in Patients with Bioprosthetic Aortic Valve and Atrial Fibrillation (Tae Lee, MS4, Stacey Grassi, PharmD, Joesph Chronowski, PhD)

Recent Grants

  • GHP Quality Improvement Grant
Content from General Links with modal content